Overview
COVID-19 and Rheumatology Care: How Does it Impact My Patients?
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
How prepared are you to manage your rheumatologic patients amidst this ongoing COVID-19 pandemic? This recorded CME-certified session with expert faculty will discuss what you need to know about rheumatology care and COVID-19.
Topics to benefit your care of RA patients include:
• Impact of immunomodulatory therapies on COVID-19 infection risk
• Vaccine considerations
• Telemedicine
• Long-hauler symptoms post-acute COVID-19 illness
This activity is intended for rheumatologists, internal medicine physicians, nurses, and other allied health
care professionals interested in the latest research and recommendations regarding rheumatology care in the midst of the pandemic.
care professionals interested in the latest research and recommendations regarding rheumatology care in the midst of the pandemic.
As the global COVID-19 pandemic enters its second year, healthcare, including rheumatology care, continues to evolve. Experts lead a discussion on ACR-recommended guidance regarding immunomodulatory treatments amidst the pandemic as well as how to best monitor and care for patients with potential “long-hauler,” immune-related symptoms after acute COVID-19 illness.
Upon completion of this activity, participants will be able to:
• Incorporate expert-recommended guidance regarding immunomodulatory treatment during the COVID-19 pandemic
• Implement the latest recommendations for modifying rheumatologic treatment secondary to COVID-19 vaccine administration
• Identify patients who have potential “long-hauler,” immune-related symptoms after acute COVID-19 illness
• Incorporate expert-recommended guidance regarding immunomodulatory treatment during the COVID-19 pandemic
• Implement the latest recommendations for modifying rheumatologic treatment secondary to COVID-19 vaccine administration
• Identify patients who have potential “long-hauler,” immune-related symptoms after acute COVID-19 illness
• Impact of immunomodulatory therapies on COVID-19 infection risk
• Immunomodulatory treatment recommendations amidst pandemic
• Vaccine advances
• Shifting care practices amidst the pandemic
Panel discussion: What else have you changed in your practice?
• Long-term considerations post-acute COVID-19 illness
Panel discussion: What would you recommend for the monitoring and care of “long-haulers?
• Immunomodulatory treatment recommendations amidst pandemic
• Vaccine advances
• Shifting care practices amidst the pandemic
Panel discussion: What else have you changed in your practice?
• Long-term considerations post-acute COVID-19 illness
Panel discussion: What would you recommend for the monitoring and care of “long-haulers?
Sponsored by the Academy for Continued Healthcare Learning (ACHL).
Supported by an educational grant from Cardinal Health.
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This activity has been approved for 0.75 contact hour.
ACPE Universal Activity Number: 0396-0000-21-008-H01-P
Activity Type(s): Knowledge
Release Date: April 6, 2021
Expiration Date: April 6, 2022
Allan Gibofsky, MD, JD, MACR, FACP, FCLM
Professor of Medicine, Healthcare Policy and Research
Weill Medical College of Cornell University
Attending Rheumatologist
Hospital for Special Surgery
New York, NY
Professor of Medicine, Healthcare Policy and Research
Weill Medical College of Cornell University
Attending Rheumatologist
Hospital for Special Surgery
New York, NY
Jonathan Jones, MD
Rheumatologist
Samaritan Rheumatology
Corvallis, OR
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been mitigated prior to this activity.
The following financial relationships have been provided:
Allan Gibofsky, MD, JD, MACR, FACP, FCLM (Faculty)
Consulting Agreements: AbbVie Inc., Acquist Therpauetics, Eli Lilly and Company, Gilead Sciences, Inc., Horizon Therapeutics, Merck, Pfizer Inc., Samumed
Speakers' Bureau: AbbVie Inc., Eli Lilly and Company, Novartis, Pfizer Inc.
Shareholder: AbbVie Inc., Horizon Therapeutics, Johnson & Johnson, and Pfizer Inc.
Jonathan Jones, MD (Faculty)
None
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, as well as the ACPE Accreditation Standards for Continuing Pharmacy Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 45 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 75% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
For questions, contact Michelle Forcier at mforcier@achlcme.org.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
(NOTE: Nurse practitioners may participate in this educational activity and earn a certificate of completing as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.)